We are live on ! Find out more
WVE icon

Wave Life Sciences

78 hedge funds and large institutions have $282M invested in Wave Life Sciences in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $3.3M | Put options by funds: $1.38M

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

19% more capital invested

Capital invested by funds: $236M → $282M (+$45.6M)

1.12% more ownership

Funds ownership: 86.03%87.15% (+1.1%)

13% less funds holding

Funds holding: 9078 (-12)

50% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 24

Holders
78
Holders Change
-12
Holders Change %
-13.33%
% of All Funds
1.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
29
Reduced
24
Closed
24
Calls
$3.3M
Puts
$1.38M
Net Calls
+$1.93M
Net Calls Change
+$638K
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$72.9M
RI
2
RTW Investments
New York
$31.8M +$14.4M +1,684,459 +99%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$28.4M -$1.48M -174,019 -5%
RG
4
Redmile Group
California
$27.4M -$3.4M -399,141 -12%
BG
5
Bellevue Group
Switzerland
$24.4M +$1.7M +200,000 +8%
BlackRock
6
BlackRock
New York
$17M -$134K -15,739 -0.9%
Primecap Management
7
Primecap Management
California
$11.6M -$495K -58,132 -4%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$10.2M -$326K -38,252 -3%
NCM
9
Nantahala Capital Management
Connecticut
$9.13M +$8.3M +974,472 New
JP Morgan Chase
10
JP Morgan Chase
New York
$7.32M +$4.27M +501,788 +180%
Morgan Stanley
11
Morgan Stanley
New York
$6.42M +$5.23M +614,025 +857%
State Street
12
State Street
Massachusetts
$4.77M +$238K +27,980 +6%
Vanguard Group
13
Vanguard Group
Pennsylvania
$3.86M +$11.5K +1,348 +0.3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.75M +$120K +14,089 +5%
Northern Trust
15
Northern Trust
Illinois
$2.68M -$34.9K -4,100 -1%
PAMU
16
Pictet Asset Management (UK)
United Kingdom
$1.82M +$1.17M +137,124 +238%
TCM
17
Tekla Capital Management
Massachusetts
$1.2M +$240K +28,134 +28%
PIM
18
Platinum Investment Management
Australia
$1.18M +$488K +57,228 +83%
Charles Schwab
19
Charles Schwab
California
$1.14M +$25.7K +3,016 +3%
SC
20
Sculptor Capital
New York
$1.13M +$1.02M +120,200 New
PP
21
PDT Partners
New York
$1.11M +$531K +62,300 +112%
N
22
Nuveen
North Carolina
$1.03M +$274K +32,218 +41%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$815K -$22.6K -2,648 -3%
SIM
24
Spark Investment Management
New York
$754K -$413K -48,481 -38%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$670K +$36.1K +4,238 +6%

WVE Hedge Fund Activity: Q1 2020 in Review

78 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2020, worth a combined $282M — up 19% from $236M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of WVE and 12 opened new positions — a net loss of 12 holders — while 24 trimmed existing stakes and 29 added.

The largest buyer was RTW Investments, adding an estimated $14.4M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $7.95M sold.

  • 78 institutional investors held Wave Life Sciences (WVE) as of Q1 2020, down from 90 in Q4 2019.
  • Funds reported $282M of Wave Life Sciences stock for Q1 2020, up 19% quarter-over-quarter.
  • 12 funds opened new Wave Life Sciences positions in Q1 2020 and 24 closed out, a net change of -12 holders.
  • The largest Wave Life Sciences buyer in Q1 2020 was RTW Investments, an estimated $14.4M added.
  • The largest Wave Life Sciences seller in Q1 2020 was ArrowMark Colorado Holdings, an estimated $7.95M sold.

Based on aggregated 13F filings for Q1 2020.